The Middle East obesity intervention market will grow through 2026, driven by increasing penetration of bariatric procedures and a growing obese population. Additionally, rapid growth in the intragastric balloon segment will help counteract declines in the gastric band segment, contributing to overall market expansion.
This Medtech 360 Report provides key market metrics for the obesity interventions device market in the Middle East region, including country-level data for major countries and aggregate data for the rest of Middle East, across a 10-year period.
- Obesity Interventions - Market Insights - Middle East (Supplemental)
Author(s): P Prasad, MS
Prasad Pallemsetty is a team lead within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, specializing in the fields of gastroenterology, bariatrics, diabetes, ENT and bronchoscopy, gynecology, and urology. In particular, he has extensive knowledge of endoscopic devices, laparoscopic devices, and minimally invasive procedures. Prasad has attended many international conferences, including ENDOCON 2016 in Mumbai and Diabetes India 2018 in Kolkata, where he gained insight into the latest trends in endoscopic gastroenterology and diabetes treatments, respectively. Prasad holds a Bachelor’s degree in Pharmacy and a Master’s degree in Pharmaceutics.
Follow Prasad on Twitter: @PPrasad_DRG